Multi-vessel Versus Culprit-vessel-only PCI for STEMI: Where Does the Jury Stand?
作者信息
Almas Talal, Akram Ayesha, Ehtesham Maryam, Ahmed Reema, Khedro Tarek, Malik Uzair, Alshaikh Lamees, Alshaikh Lina, Sattar Yasar, Hassan Virk Hafeez Ul
机构信息
RCSI University of Medicine and Health Sciences, Dublin, Ireland.
Rawalpindi Medical University, Rawalpindi, Pakistan.
出版信息
Ann Med Surg (Lond). 2021 Apr 24;65:102343. doi: 10.1016/j.amsu.2021.102343. eCollection 2021 May.
Abstract
摘要
相似文献
1
Multi-vessel Versus Culprit-vessel-only PCI for STEMI: Where Does the Jury Stand?
Ann Med Surg (Lond). 2021 Apr 24;65:102343. doi: 10.1016/j.amsu.2021.102343. eCollection 2021 May.
2
Culprit vessel only versus multivessel and staged percutaneous coronary intervention for multivessel disease in patients presenting with ST-segment elevation myocardial infarction: a pairwise and network meta-analysis.
J Am Coll Cardiol. 2011 Aug 9;58(7):692-703. doi: 10.1016/j.jacc.2011.03.046.
3
Multi-vessel versus culprit-vessel and staged percutaneous coronary intervention in STEMI patients with multivessel disease: a meta-analysis of randomized controlled trials.
Cardiovasc Revasc Med. 2014 Nov-Dec;15(8):408-13. doi: 10.1016/j.carrev.2014.10.007. Epub 2014 Oct 16.
4
Culprit vessel PCI versus traditional cath and PCI for STEMI.
J Invasive Cardiol. 2008 May;20(5):224-8.
5
Culprit vessel percutaneous coronary intervention versus multivessel and staged percutaneous coronary intervention for ST-segment elevation myocardial infarction patients with multivessel disease.
JACC Cardiovasc Interv. 2010 Jan;3(1):22-31. doi: 10.1016/j.jcin.2009.10.017.
6
Multivessel Versus Culprit-Only Revascularization in STEMI and Multivessel Coronary Artery Disease: Meta-Analysis of Randomized Trials.
JACC Cardiovasc Interv. 2020 Jul 13;13(13):1571-1582. doi: 10.1016/j.jcin.2020.04.055.
7
Multi-vessel stenting during primary percutaneous coronary intervention for acute myocardial infarction. A single-center experience.
Clin Res Cardiol. 2008 Jan;97(1):32-8. doi: 10.1007/s00392-007-0570-4. Epub 2007 Aug 17.
8
Culprit vessel only versus "one-week" staged percutaneous coronary intervention for multivessel disease in patients presenting with ST-segment elevation myocardial infarction.
J Geriatr Cardiol. 2015 May;12(3):226-31. doi: 10.11909/j.issn.1671-5411.2015.03.001.
9
Prognosis of STEMI Patients with Multi-Vessel Disease Undergoing Culprit-Only PCI without Significant Residual Ischemia on Non-Invasive Stress Testing.
PLoS One. 2015 Sep 25;10(9):e0138474. doi: 10.1371/journal.pone.0138474. eCollection 2015.
10
Multivessel PCI for Acute Myocardial Infarction: Where Do We Stand After The COMPLETE Trial?
Curr Cardiol Rep. 2020 Jul 25;22(9):97. doi: 10.1007/s11886-020-01340-y.
本文引用的文献
1
Meta-Analysis of Complete versus Culprit-Only Revascularization in Patients with ST-Segment Elevation Myocardial Infarction and Multivessel Coronary Disease.
Am J Cardiol. 2020 Nov 15;135:40-49. doi: 10.1016/j.amjcard.2020.08.030. Epub 2020 Aug 29.
2
Multivessel or Culprit Vessel-Only Percutaneous Coronary Intervention for Patients With Acute Myocardial Infarction and Cardiogenic Shock: Real-World Evidence in Support of CULPRIT-SHOCK.
JAMA Intern Med. 2020 Oct 1;180(10):1280-1283. doi: 10.1001/jamainternmed.2020.3400.
3
Meta-Analysis and Trial Sequential Analysis of Randomized Controlled Trials for Multivessel PCI Versus Culprit Artery Only PCI in STEMI Without Cardiogenic Shock.
Curr Probl Cardiol. 2021 Mar;46(3):100646. doi: 10.1016/j.cpcardiol.2020.100646. Epub 2020 Jun 13.
4
Multivessel Versus Culprit-Only Revascularization in STEMI and Multivessel Coronary Artery Disease: Meta-Analysis of Randomized Trials.
JACC Cardiovasc Interv. 2020 Jul 13;13(13):1571-1582. doi: 10.1016/j.jcin.2020.04.055.
5
Multivessel versus culprit-only PCI in STEMI patients with multivessel disease: meta-analysis of randomized controlled trials.
Clin Res Cardiol. 2020 Nov;109(11):1381-1391. doi: 10.1007/s00392-020-01637-6. Epub 2020 Apr 1.
6
Meta-Analysis Comparing Complete Versus Infarct-Related Artery Revascularization in Patients With ST-Elevation Myocardial Infarction and Multivessel Coronary Disease.
Am J Cardiol. 2020 Feb 15;125(4):513-520. doi: 10.1016/j.amjcard.2019.11.017. Epub 2019 Nov 19.
7
Timing of Staged Nonculprit Artery Revascularization in Patients With ST-Segment Elevation Myocardial Infarction: COMPLETE Trial.
J Am Coll Cardiol. 2019 Dec 3;74(22):2713-2723. doi: 10.1016/j.jacc.2019.09.051.
8
Design and rationale of the COMPLETE trial: A randomized, comparative effectiveness study of complete versus culprit-only percutaneous coronary intervention to treat multivessel coronary artery disease in patients presenting with ST-segment elevation myocardial infarction.
Am Heart J. 2019 Sep;215:157-166. doi: 10.1016/j.ahj.2019.06.006. Epub 2019 Jun 18.
9
Optimized Treatment of ST-Elevation Myocardial Infarction.
Circ Res. 2019 Jul 5;125(2):245-258. doi: 10.1161/CIRCRESAHA.119.315344. Epub 2019 Jul 3.
10
Metaanalysis of Multivessel vs Culprit Artery Only Percutaneous Coronary Intervention in ST Elevation Myocardial Infarction.
Ochsner J. 2019 Summer;19(2):107-115. doi: 10.31486/toj.18.0033.
Zotero 插件